Celgene, OncoMed in $177M Cancer Stem Cell Deal – PharmaLive (press release) (subscription)
|
Celgene, OncoMed in $177M Cancer Stem Cell Deal
PharmaLive (press release) (subscription) 3, 2013 (GLOBE NEWSWIRE) — OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED) and Celgene Corporation (Nasdaq:CELG) today announced an agreement to jointly develop and commercialize up to six anti-cancer stem cell (CSC) product candidates from … |
